Xiao Ping, Guo Tao, Yin Rutie
Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Obstetrics and Gynecology, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu, China.
Front Med (Lausanne). 2022 Nov 2;9:1018573. doi: 10.3389/fmed.2022.1018573. eCollection 2022.
Gestational trophoblastic neoplasia is an uncommon disease, whose clinical manifestations are similar to ectopic pregnancy, thus some rare pelvic lesion can be misdiagnosed as ectopic pregnancy.
This study was presented to investigate the characteristics of gestational trophoblastic neoplasia misdiagnosed as ectopic pregnancy and reduce the misdiagnosis.
The clinicopathological data for 14 cases of gestational trophoblastic neoplasia misdiagnosed as ectopic pregnancy at West China Second Hospital Sichuan University from January 2006 to December 2020 were retrospectively analyzed.
The main clinical manifestations were amenorrhea, abnormal vaginal bleeding, and abdominal pain. At initial diagnosis, the serum hCG level was >10,000 mIU/mL in 5 patients and <10,000 mIU/mL in 7 patients, and a positive urine pregnancy test alone was found in 2 patients. Vaginal ultrasonography showed no abnormalities in 7 cases, adnexal mass in 5 cases, and tubal thickening in 2 cases. The patient's previous pregnancy was an abortion in 7 cases, full-term in 4 cases, and a hydatidiform mole in 3 cases. Clinical stage: 3 cases were stage I, 3 were stage II, 7 were stage III, and 1 case was stage IV (liver and spleen metastases). The median FIGO prognostic score was 13.5 points (12-21 points), with 9 cases having a score >13 points (very high risk). From 14 patients, only 3 had molar pregnancy previously. Only 3 patients had no metastasis at GTN diagnosis (from these 3, only one after molar pregnancy). After chemotherapy alone or in combination with surgery, all patients survived, with a median follow-up of 84 months (23-102 months).
If we have positive hCG, without a sonographic topic gestation confirmation, associated with metastatic lesions, the GTN diagnosis should be considered instead of ectopic pregnancy, if the patient have had a pregnancy once during her life.
妊娠滋养细胞肿瘤是一种罕见疾病,其临床表现与异位妊娠相似,因此一些罕见的盆腔病变可能被误诊为异位妊娠。
本研究旨在探讨被误诊为异位妊娠的妊娠滋养细胞肿瘤的特征,以减少误诊。
回顾性分析2006年1月至2020年12月在四川大学华西第二医院被误诊为异位妊娠的14例妊娠滋养细胞肿瘤的临床病理资料。
主要临床表现为闭经、阴道异常出血和腹痛。初诊时,5例患者血清hCG水平>10,000 mIU/mL,7例患者<10,000 mIU/mL,2例患者仅尿妊娠试验阳性。阴道超声检查显示7例无异常,5例附件包块,2例输卵管增厚。患者既往妊娠情况:7例为流产,4例为足月产,3例为葡萄胎。临床分期:Ⅰ期3例,Ⅱ期3例,Ⅲ期7例,Ⅳ期1例(肝脾转移)。国际妇产科联盟(FIGO)预后评分中位数为13.5分(12 - 21分),9例评分>13分(极高危)。14例患者中,仅3例既往有葡萄胎妊娠史。仅3例妊娠滋养细胞肿瘤诊断时无转移(这3例中,仅1例有葡萄胎妊娠史)。单纯化疗或联合手术治疗后,所有患者均存活,中位随访时间为84个月(23 - 102个月)。
如果患者hCG阳性,超声未证实有宫内妊娠且伴有转移灶,若患者一生中曾有过一次妊娠,则应考虑诊断为妊娠滋养细胞肿瘤而非异位妊娠。